Altamira Therapeutics Ltd
CYTO
CYTO was delisted on the 19th of December, 2024.
1 hedge funds and large institutions have $0 invested in Altamira Therapeutics Ltd in 2025 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
50% less funds holding
Funds holding: 2 → 1 (-1)
100% less capital invested
Capital invested by funds: $1.21K → $0 (-$1.21K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$1.21K |
CYTO Hedge Fund Activity: Q1 2025 in Review
1 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Altamira Therapeutics Ltd (CYTO) for Q1 2025, worth a combined $0 — down 100% from $1.21K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of CYTO and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was XTX Topco, exiting entirely with an estimated $1.21K sold.
- 1 institutional investor held Altamira Therapeutics Ltd (CYTO) as of Q1 2025, down from 2 in Q4 2024.
- Funds reported $0 of Altamira Therapeutics Ltd stock for Q1 2025, down 100% quarter-over-quarter.
- 0 funds opened new Altamira Therapeutics Ltd positions in Q1 2025 and 1 closed out, a net change of -1 holder.
- The largest Altamira Therapeutics Ltd seller in Q1 2025 was XTX Topco, an estimated $1.21K sold.
Based on aggregated 13F filings for Q1 2025.